Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 559.17 | 459.95 | 661.23 | 624.81 |
Total Revenue | 559.17 | 459.95 | 661.23 | 624.81 |
Costof Revenue Total | 230.12 | 310.71 | 337.83 | 259.47 |
Gross Profit | 329.05 | 149.24 | 323.40 | 365.33 |
Selling/ General/ Admin Expenses Total | 149.57 | 212.51 | 326.71 | 275.97 |
Depreciation/ Amortization | 36.71 | 39.12 | 43.66 | 45.59 |
Unusual Expense( Income) | -36.03 | -99.10 | -1,675.42 | 4.00 |
Other Operating Expenses Total | 199.54 | 2.46 | 6.44 | 4.32 |
Total Operating Expense | 579.91 | 465.70 | -960.78 | 589.36 |
Operating Income | -20.74 | -5.75 | 1,622.01 | 35.45 |
Interest Inc( Exp) Net- Non- Op Total | -35.80 | 117.83 | -1,760.48 | -1,820.33 |
Other Net | 25.80 | 1.48 | 2.84 | 2.38 |
Net Income Before Taxes | 1.48 | 12.81 | 1,448.81 | -144.25 |
Provisionfor Income Taxes | 2.98 | 46.55 | 370.91 | 1.96 |
Net Income After Taxes | -1.50 | -33.75 | 1,077.90 | -146.20 |
Minority Interest | 0.33 | 0.51 | -0.02 | -0.04 |
Net Income Before Extra Items | -1.17 | -33.24 | 1,077.89 | -146.24 |
Net Income | -1.17 | -33.24 | 1,077.89 | -147.70 |
Income Availableto Com Excl Extra Ord | -1.17 | -33.24 | 1,077.89 | -146.24 |
Income Availableto Com Incl Extra Ord | -1.17 | -33.24 | 1,077.89 | -147.70 |
Diluted Net Income | -1.17 | -33.24 | 1,077.89 | -147.70 |
Diluted Weighted Average Shares | 6.16 | 6.13 | 6.13 | 6.13 |
Diluted EPS Excluding Extra Ord Items | -0.19 | -5.43 | 175.98 | -23.88 |
Diluted Normalized EPS | -3.99 | -16.50 | -1.82 | -23.45 |
Gain( Loss)on Saleof Assets | - | 52.93 | 0.07 | -0.38 |
Total Extraordinary Items | - | - | 0.00 | -1.46 |
Panacea Biotec Dividend Panacea Biotec Bonus Panacea Biotec News Panacea Biotec AGM Panacea Biotec Rights Panacea Biotec Splits Panacea Biotec Board Meetings Panacea Biotec Key Metrics Panacea Biotec Shareholdings Panacea Biotec Balance Sheet Panacea Biotec Cashflow Panacea Biotec Q1 Results Panacea Biotec Q2 Results Panacea Biotec Q3 Results Panacea Biotec Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks